A Randomized Controlled comparison of different methods of Phenylephrine for Hemodynamic Support During Spinal Anesthesia for Cesarean Delivery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15006538

Enrollment

Unknown

Registered

2015-05-21

Start date

2014-08-26

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamic Support During Spinal Anesthesia for Cesarean Delivery

Interventions

continue infusion of phenylephrine group:continue infusion Phenylephrine 50ug/min in vein

phenylephrine bolus group:phenylephrine bolus 100ug in vein

infusion of normal saline group:continue infusion of normal saline in vein

Eligibility

Sex/Gender

Female

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Parturients >=37 weeks' gestation, ASA physical status ? or ?? scheduled for elective cesarean delivery

Exclusion criteria

Exclusion criteria: Exclusion criteria were allergy or hypersensitivity to phenylephrine, hypertension, multiple gestation, known fetal abnormalities, diabetes mellitus, polyhydramnios, body weight less than 50 and more than 100 kg, height less than 150 and more than 180 cm, anemia (hemoglobin concentration <10 g/dL), or clotting diathesis.

Design outcomes

Primary

Measure	Time frame
blood pressure;	—

Secondary

Measure	Time frame
Umbilical Vein;	—

Countries

China

Contacts

Public ContactHUANG SHAO QIANG

timrobbins71@163.com+86 21 63455050

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026